stockrowBecton, Dickinson and Company (BDX) vs West Pharmaceutical Services, Inc. (WST)
- Becton, Dickinson and Company BDX 212.96 +1.80%
- West Pharmaceutical Services, Inc. WST 392.97 −3.87%
Becton, Dickinson and Company and West Pharmaceutical Services, Inc. are both Medical Instruments & Supplies companies. Becton, Dickinson and Company is the larger, with a market value of $58.2B against $27.3B — 2.1× the size. West Pharmaceutical Services, Inc. trades at the lower P/E: 43.8× against 64.1×. West Pharmaceutical Services, Inc. grew revenue faster over the last twelve months: 12.6% against −2.55%. West Pharmaceutical Services, Inc. has the higher net margin (18.8% vs 4.52%) and the higher return on invested capital (18.0% vs 3.89%). Both pay a dividend; Becton, Dickinson and Company yields more (1.87% vs 0.22%). Across the 23 metrics below, West Pharmaceutical Services, Inc. leads on 13 and Becton, Dickinson and Company on 10.
Valuation
Profitability
| Metric | BDX | WST | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 50.26% | 37.59% | 53.60% |
| Operating margin | 11.07% | 22.97% | 1.97% |
| Net margin | 4.52% | 18.81% | 0.00% |
| Free cash flow margin | 15.37% | 13.35% | 2.36% |
| Return on equity | 3.77% | 21.23% | 0.00% |
| Return on assets | 1.78% | 15.65% | 0.00% |
| Return on invested capital | 3.89% | 18.01% | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack